API CAS 1140909-48-3 Cabozantinib Malate Raw Cabozantinib Malate Powder Purity Cabozantinib Malate

• Customization: Available
• Powder: Yes
• Customized: Customized
• Model NO.: D-Sung Cabozantinib Malate
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Adult
• State: Powder
• Purity: >99%
• Product Name: Cabozantinib Malate
• Name: Cabozantinib Malate Powder
• Appearance: White Crystalline Powder
• Color: White
• Grade: Pharmaceutical Grade
• Assay: HPLC 99%
• Application: Anthelmintics
• Specific: COA
• Test Method: HPLC
• CAS No: 1140909-48-3
• Mf: C32h30fn3o10
• MW: 635.5931032
• Water: 3.4%
• Heavy Metals: 5ppm
• Residue on Ignition: 0.08%
• Transport Package: Negotiable
• Specification: 99%
• Trademark: D-Sung
• Origin: Xi′an Shaanxi
• Production Capacity: 500kg/Month

Product Description

API CAS 1140909-48-3 Cabozantinib Malate Raw Cabozantinib Malate Powder Purity Cabozantinib Malate

Product Description

Product Details

Product Name	Cabozantinib Malate
Appearance	White Crystalline Powder
CAS No	1140909-48-3
MF	C32H30FN3O10

Cabozantinib malate was developed by Exelixis Biopharmaceutical Company, USA. It mainly targets MET and VEGFR2 tyrosine kinases, which are related to the growth and spread of prostate cancer, to inhibit tumor metastasis and angiogenesis.

Application&Function

Cabozantinib Malate is an anti-cancer drug.Cabozantinib Malate should be stored in a well-closed container at low temperature, keep away from moisture, heat and light.
Cabozantinib (marketed under the tradename Cometriq, formerly known as XL184) is a potent VEGFR2 inhibitor with IC50 of 0.035 nM. XL-184 also displays potent activity against Met, Ret, Kit, FLT1, FLT3, FLT4, Tie2, and AXL. XL184 at low concentration(0.1-0.5 μM) is sufficient to induce marked inhibition of constitutive and inducible Met phosphorylation and its resultant downstream signaling in MPNST cells, and inhibit HGF-induced MPNST cell migration and invasion

Specification